https://www.thebodypro.com/tag/men-who-have-sex-with-men

Men Who Have Sex With Men

The Latest

magnifying glass

This Week in HIV Research: The Importance of Challenging Our Assumptions

Feb. 25, 2021: High HCV SVR among people using substances; geographic HIV care disparities among Black Americans; self-administered imiquimod vs. ASIL excision; PrEP uptake in syringe service programs.

By Barbara Jungwirth and Myles Helfand
parachute

This Week in HIV Research: What Risk Compensation?

Feb. 4, 2021: STI rates among PrEP users; how Medicaid expansion affects HIV testing and PrEP rates; utilizing mental health care providers in PrEP uptake; adapting HIV care in the COVID era.

By Barbara Jungwirth and Myles Helfand
doctor patient hands

This Week in HIV Research: Health in Unity

Jan. 21, 2021: Dyad-level interventions in serodiscordant relationships; using social media to improve PrEP uptake; HCV prevalence among MSM; the irrelevance of doxycycline prophylaxis against mycoplasma genitalium.

By Barbara Jungwirth and Myles Helfand
drug counseling

Combination of Naltrexone and Bupropion May Help Treat Meth Use Disorder, Study Finds

Participants on the combination were almost six times more likely to have meth-negative urine samples after six weeks than those on the placebo. They also reported a slight reduction in cravings.

By Larry Buhl
green light

U.S. Waits on Approval of Long-Acting HIV Treatment Cabotegravir and Rilpivirine as European Union Gives the Green Light

The era of once-a-month HIV treatment has begun in the European Union—and it may soon commence in the U.S. as well. Long-acting pre-exposure prophylaxis (PrEP) is also on the horizon.

By Michael Broder
Promo Image

This Week in HIV Research: Our Immensely Intersectional Epidemic

Dec. 3, 2020: A simple scoring system for PrEP referral; integrating meth use and HIV prevention interventions; genetically linked HIV strains cross county lines; viral suppression rates in first vs. second pregnancies.

By Barbara Jungwirth and Myles Helfand
Marlon M. Bailey and Tonia Poteat

LGBTQ Health and Well-Being: Where Is the U.S. Right Now?

Tonia Poteat, Ph.D., PA-C, M.P.H., and Marlon M. Bailey, Ph.D., dive into the important takeaways of a major new report on sexual and gender diverse populations in the U.S.

By Terri Wilder, M.S.W.
chlamydia

DoxyPEP for STIs: Are We Ready for Prophylactic Doxycycline for MSM on HIV PrEP?

A recent expert debate explored the pros and cons of prescribing the antibiotic as a preventive measure for a subset of people at especially high risk for sexually transmitted infections.

By Michael Broder
Promo Image

This Week in HIV Research: What’s in Your Head

Nov. 12, 2020: The most significant burdens experienced by PLWH; asymptomatic neurocognitive impairment and HAND risk; financial incentives for improving HIV knowledge and testing; linking HIV and COVID-19 testing.

By Barbara Jungwirth and Myles Helfand
doctor talking to unrecognizable patient

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

The process of choosing between PrEP options is often not straightforward. Oni Blackstock, M.D., explains how providers can help ensure their patients end up with the most successful option for them.

By Terri Wilder, M.S.W.